Logo image of CANF

CAN FITE BIOPHARMA LTD-ADR (CANF) Stock Analyst Ratings

NYSEARCA:CANF - NYSE Arca - US13471N3008 - ADR - Currency: USD

1.81  -0.1 (-5.24%)

After market: 1.8482 +0.04 (+2.11%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CANF. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.58. This target is 318.63% above the current price.
CANF was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CANF.
In the previous month the buy percentage consensus was at a similar level.
CANF was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

CANF Historical Analyst RatingsCANF Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -2 -1 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 1.817.507.587.587.80 - 314.52% 318.63% 318.63% 330.94%

Related screens

CANF Current Analyst RatingCANF Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-02-18 D. Boral Capital Maintains Buy -> Buy
2024-12-31 D. Boral Capital Maintains Buy -> Buy
2024-12-05 D. Boral Capital Maintains Buy -> Buy
2024-11-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-10 EF Hutton Maintains Buy -> Buy
2024-09-24 EF Hutton Maintains Buy -> Buy
2024-08-30 EF Hutton Maintains Buy -> Buy
2024-07-17 EF Hutton Initiate Buy
2024-05-09 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-24 HC Wainwright & Co. Maintains Buy -> Buy
2023-06-02 HC Wainwright & Co. Reiterate Buy
2023-03-13 HC Wainwright & Co. Reiterate Buy